Intermittent Hypoxia and Upper Extremity EMG Recordings in Individuals With Spinal Cord Injury
Launched by SHIRLEY RYAN ABILITYLAB · Aug 22, 2022
Trial Information
Current as of July 09, 2025
Completed
Keywords
ClinConnect Summary
It has been shown previously that there is an increase in strength in survivors of spinal cord injury after brief bouts of Acute Intermittent Hypoxia. In this study, participants are fitted with a high density EMG electrode on the biceps brachii, and attached to a load cell at the wrist, they are asked to flex and extend their elbow at various levels of intensity. This is performed before and after the 30 minute session of AIH. The investigators hope to identify specific types of motor units of the upper extremity of survivors of spinal cord injury after AIH to help further our understandin...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • History of Spinal Cord Injury from C3-T4
- • Non-progressive spinal cord injury
- • More than 6 months since initial Spinal Cord injury
- • Ability to understand and willingness to sign written informed consent
- Exclusion Criteria:
- • Presence of any of the following medical conditions: Congestive heart failure, arrhythmia, uncontrolled high blood pressure, uncontrolled diabetes mellitus, COPD/emphysema and severe asthma
- • Persons with known coronary artery disease, a history of myocardial infarction, or known carotid or intracerebral artery stenosis
- • Medical clearance will be required if participant is taking any other investigational agents
- • Women who are pregnant or nursing
- • Individuals with tracheostomy
- • Cannot pursue other research studies which may interfere
- • Unable to consent
- • Individuals who are not yet adults (infants, children, teenagers)
- • Prisoners
About Shirley Ryan Abilitylab
Shirley Ryan AbilityLab is a leading research and rehabilitation institute dedicated to advancing the science of physical medicine and rehabilitation. Based in Chicago, Illinois, the organization integrates clinical care, research, and education to enhance the quality of life for individuals with disabilities and chronic conditions. Known for its innovative approach, Shirley Ryan AbilityLab conducts clinical trials that aim to develop and evaluate cutting-edge therapies and technologies, fostering a collaborative environment that bridges the gap between laboratory research and patient care. Through its commitment to excellence, the institute strives to empower patients and improve outcomes in rehabilitation medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
William Z Rymer, MD, PhD
Principal Investigator
Shirley Ryan AbilityLab
Milap Sandhu, PhD
Principal Investigator
Shirley Ryan AbilityLab
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials